🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

28,45 USD

Máx. histórico

61,71

1719 días

Caída desde máximo

-53,90%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-1,25%

Cierre anterior

28,81

Rango de hoy

28,38 – 28,69

Volumen hoy

23.529.537

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
37,93 (puede no estar actualizado)
Dividend yield
5,97% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 días
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,05%
Fecha de pago Importe por participación
31/07/1996 0,0474 USD
08/05/1996 0,0474 USD
07/02/1996 0,0474 USD
08/11/1995 0,0411 USD
02/08/1995 0,0411 USD
08/05/1995 0,0411 USD
06/02/1995 0,0411 USD
04/11/1994 0,0372 USD
01/08/1994 0,0372 USD
09/05/1994 0,0372 USD
07/02/1994 0,0372 USD
05/11/1993 0,0332 USD
02/08/1993 0,0332 USD
10/05/1993 0,0332 USD
08/02/1993 0,0332 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/12/2017 34,90 35,32 34,83 35,29 +2,03% 1,41% 39.820.015
14/12/2017 34,85 35,00 34,48 34,59 -0,49% 1,50% 15.585.393
13/12/2017 34,70 34,91 34,60 34,76 +0,16% 0,90% 16.639.709
12/12/2017 34,50 34,93 34,39 34,71 +1,02% 1,57% 23.700.139
11/12/2017 34,19 34,40 33,86 34,35 +1,31% 1,58% 15.138.497
08/12/2017 33,51 33,94 33,51 33,91 +0,68% 1,27% 15.705.759
07/12/2017 33,74 33,81 33,35 33,68 -0,17% 1,38% 16.661.421
06/12/2017 33,76 34,04 33,69 33,74 -0,20% 1,04% 18.317.677
05/12/2017 34,08 34,34 33,69 33,80 -1,19% 1,89% 23.525.912
04/12/2017 34,62 34,74 34,20 34,21 -0,80% 1,56% 14.847.487
01/12/2017 34,43 34,63 34,17 34,49 +0,25% 1,35% 19.588.485
30/11/2017 34,35 34,61 34,23 34,40 +0,14% 1,10% 24.063.663
29/11/2017 34,10 34,54 34,04 34,35 +1,00% 1,47% 16.122.827
28/11/2017 33,77 34,05 33,70 34,01 +1,01% 1,04% 13.687.033
27/11/2017 33,70 33,82 33,57 33,67 +0,00% 0,76% 10.848.611
24/11/2017 33,69 33,74 33,56 33,67 +0,17% 0,53% 6.742.754
22/11/2017 33,63 33,68 33,51 33,61 -0,31% 0,51% 11.122.967
21/11/2017 33,59 33,90 33,57 33,72 +0,54% 0,99% 13.333.100
20/11/2017 33,57 33,63 33,46 33,54 -0,06% 0,51% 12.455.540
17/11/2017 33,56 33,67 33,37 33,56 -0,53% 0,90% 15.649.265
16/11/2017 33,53 33,76 33,44 33,74 +0,57% 0,93% 13.625.901
15/11/2017 33,47 33,68 33,43 33,55 -0,06% 0,77% 13.646.138
14/11/2017 33,44 33,87 33,42 33,57 +0,23% 1,36% 17.278.538
13/11/2017 33,42 33,66 33,34 33,49 +0,34% 0,97% 25.072.657
10/11/2017 33,30 33,39 33,02 33,38 -0,06% 1,11% 15.858.589
09/11/2017 33,28 33,44 33,06 33,40 -0,40% 1,17% 14.088.713
08/11/2017 33,56 33,58 33,24 33,53 -0,06% 1,02% 14.302.148
07/11/2017 33,49 33,61 33,43 33,55 +0,11% 0,51% 11.480.906
06/11/2017 33,77 33,79 33,32 33,51 -0,65% 1,38% 11.200.542
03/11/2017 33,63 33,74 33,51 33,73 +0,25% 0,68% 9.358.255